Trichomoniasis

Trichomoniasis is a sexually transmitted disease caused by a parasite. It affects both women and men, but symptoms are more common in women. Symptoms in women include a green or yellow discharge from the vagina, itching in or near the vagina and discomfort with urination. Most men with trichomoniasis don't have any symptoms, but it can cause irritation inside the penis. You can cure trichomoniasis with antibiotics. In men, the infection usually goes away on its own without causing symptoms. But an infected man can continue to infect or reinfect a woman until he gets treated. So it's important that both partners get treated at the same time. Correct usage of latex condoms greatly reduces, but does not eliminate, the risk of catching or spreading trichomoniasis.

What is Trichomoniasis?

The protozoan parasitic species Trichomonas vaginalis (also commonly referred to as “trich”) and the condition it causes (known as trichomoniasis) likely represents the most abundant non-viral sexually transmitted infection worldwide.

What Causes Trichomoniasis?

Trichomoniasis Symptoms and Complications

Trichomoniasis Diagnosis

Trichomoniasis Treatment

Latest Trichomoniasis News and Research

Vulvovaginitis and the microbiome: a review of the diagnosis and treatment of acute and recurrent infection

Researchers explored the relationship between microbiome and vulvovaginitis.

11 Apr 2023

Study evaluates the use of flow cytometry in diagnosing male urethritis

According to the World Health Organization, the global prevalence estimates of sexually transmitted infections for men in 2016 were 2.7% for chlamydia, 0.7% for gonorrhea and 0.6% for trichomoniasis. In men, these and other sexually transmitted infections may lead to urethritis, inflammation of the urethra.

3 Dec 2020

A million a day: STIs are a worldwide epidemic, declares WHO

STIs continue to rise globally, with more than 1 million new STIs of just four types being reported every day, according to a new report from the World Health Organization (WHO). This comes to over 376 million new STIs a year among people between 15 and 49 years.

6 Jun 2019

Survey results highlight the need for better communication between patients and HCPs about bacterial vaginosis

According to an online survey, although healthcare providers report sharing crucial information on bacterial vaginosis with patients, the associated risks of the condition remain a mystery to many women, indicating a significant disconnect.

16 Oct 2018

New study could change the way doctors treat a common STD

A new study led by an infectious disease epidemiologist at Tulane University School of Public Health and Tropical Medicine could change the way doctors treat a common sexually transmitted disease.

7 Oct 2018

New survey highlights need for BV awareness and education to ensure proper care

Lupin Pharmaceuticals Inc., the U.S. wholly owned subsidiary of Lupin Limited, dedicated to delivering high-quality medications trusted by healthcare professionals and women across many treatment areas, has partnered with the National Association of Nurse Practitioners in Women's Health to conduct a national online survey of 301 HCPs (including OB/GYNs and NP/PAs) who treat women with bacterial vaginosis (BV).

4 May 2018

Sleeping sickness actually caused by acceleration of biological clocks

Sleeping sickness could use a more encompassing moniker. An international study from the O'Donnell Brain Institute shows one of Africa's most lethal diseases is actually a circadian rhythm disorder caused by the acceleration of biological clocks controlling a range of vital functions besides sleep.

4 Jan 2018

Short- and long-term ADHD medication users have lower risk of STIs, study finds

Attention-deficit/hyperactivity disorder (ADHD) increases the risk of subsequent sexually transmitted infections (STIs) among adolescent and young adult populations by about three times, reports a study published in the January 2018 issue of the Journal of the American Academy of Child and Adolescent Psychiatry.

3 Jan 2018

UK study finds that e-STI testing nearly doubles testing uptake

The randomized controlled trial of more than 2,000 people in Lambeth and Southwark was led by the London School of Hygiene & Tropical Medicine and King's College London¹, in partnership with SH:24, a digital sexual health service.

27 Dec 2017

Parasite's biological clock could help improve treatments for deadly sleeping sickness

The parasite that causes deadly sleeping sickness has its own biological clock that makes it more vulnerable to medications during the afternoon, according to international research that may help improve treatments for one of Africa's most lethal diseases.

24 Mar 2017

Sixty-ninth World Health Assembly comes to end after approving many new resolutions

The Sixty-ninth World Health Assembly closed today after approving new resolutions on WHO's Framework for Engagement with Non-State Actors; the Sustainable Development Goals; the International Health Regulations; tobacco control; road traffic deaths and injuries; nutrition; HIV, hepatitis and STIs; mycetoma; research and development; access to medicines and integrated health services.

31 May 2016

Mexican engineer designs new ring that can help diagnose sexually transmitted diseases

A ring with the ability to diagnose sexually transmitted diseases like syphilis, gonorrhea, chlamydia and trichomoniasis was designed by the Mexican Ernesto Rodríguez Leal.

24 Aug 2015

HIVMA's updated HIV care guidelines show doctors should focus on common health conditions

The HIV Medicine Association of the Infectious Diseases Society of America has updated its HIV care guidelines to reflect the fact that people with HIV are now living normal life spans, and their physicians need to focus on preventive care, including screening for high cholesterol, diabetes and osteoporosis.

15 Nov 2013

Research could lead to new ways to combat chlamydia

A protein secreted by the chlamydia bug has a very unusual structure, according to scientists in the School of Medicine at The University of Texas Health Science Center San Antonio. The discovery of the protein's shape could lead to novel strategies for diagnosing and treating chlamydia, a sexually transmitted disease that infects an estimated 2.8 million people in the U.S. each year.

12 Jun 2013

Common sugar molecule promising target for development of broad-spectrum vaccine

Developing new vaccines to protect against diseases that plague humans is fraught with numerous challenges-one being that microbes tend to vary how they look on the surface to avoid being identified and destroyed by the immune system. However, researchers from Brigham and Women's Hospital (BWH) have discovered a sugar polymer that is common on the cell surface of several pathogens.

28 May 2013

Military women more likely to contract sexually transmitted infections: Study

As the number of women in the military increases, so does the need for improved gynecologic care. Military women may be more likely to engage in high-risk sexual practices, be less likely to consistently use barrier contraception, and, therefore, more likely to contract sexually transmitted infections (STIs), according to research recently released by a physician at Women & Infants Hospital of Rhode Island.

29 Jan 2013

Researchers identify mechanism that explains link between trichomoniasis and prostate cancer

Researchers have identified a way in which men can develop prostate cancer after contracting trichomoniasis, a curable but often overlooked sexually transmitted disease.

30 Aug 2012

Declining circumcision rates in the US raise healthcare costs and disease risk

A team of disease experts and health economists at Johns Hopkins warns that steadily declining rates of U.S. infant male circumcision could add more than $4.4 billion in avoidable health care costs if rates over the next decade drop to levels now seen in Europe.

21 Aug 2012

Declining rates of circumcision in US infant males could add billions to health care costs

21 Aug 2012

BioDiem granted European patent for antimicrobial drug

Australian vaccine development company BioDiem Ltd (ASX: BDM) announced today the successful granting of a key European patent for its synthetic antimicrobial compound BDM-I. BDM-I is a novel compound active against a range of pathogenic micro-organisms including bacteria, fungi and protozoa. The patent provides protection around BDM-I as a treatment for vulvovaginitis, a general term for inflammation of the vulva or vagina.

7 Aug 2012

Trichomoniasis

Overview

What Causes Trichomoniasis?

Trichomoniasis Symptoms and Complications

Trichomoniasis Diagnosis

Feature Articles

Trichomoniasis Treatment

Latest Trichomoniasis News and Research

Vulvovaginitis and the microbiome: a review of the diagnosis and treatment of acute and recurrent infection

Study evaluates the use of flow cytometry in diagnosing male urethritis

A million a day: STIs are a worldwide epidemic, declares WHO

Survey results highlight the need for better communication between patients and HCPs about bacterial vaginosis

New study could change the way doctors treat a common STD

New survey highlights need for BV awareness and education to ensure proper care

Sleeping sickness actually caused by acceleration of biological clocks

Short- and long-term ADHD medication users have lower risk of STIs, study finds

UK study finds that e-STI testing nearly doubles testing uptake

Parasite's biological clock could help improve treatments for deadly sleeping sickness

Sixty-ninth World Health Assembly comes to end after approving many new resolutions

Mexican engineer designs new ring that can help diagnose sexually transmitted diseases

HIVMA's updated HIV care guidelines show doctors should focus on common health conditions

Research could lead to new ways to combat chlamydia

Common sugar molecule promising target for development of broad-spectrum vaccine

Military women more likely to contract sexually transmitted infections: Study

Researchers identify mechanism that explains link between trichomoniasis and prostate cancer

Declining circumcision rates in the US raise healthcare costs and disease risk

Declining rates of circumcision in US infant males could add billions to health care costs

BioDiem granted European patent for antimicrobial drug

Innovations in baculovirus–insect cell expression systems

Compound Management and its Crucial Role in Early Pharmaceutical Research

Natural products: the next frontier in drug discovery

Trichomoniasis

Overview

Feature Articles

Trichomoniasis Treatment

Latest Trichomoniasis News and Research

Innovations in baculovirus–insect cell expression systems

Compound Management and its Crucial Role in Early Pharmaceutical Research

Natural products: the next frontier in drug discovery

Newsletters you may be interested in